Evidence map›Paper›PMID 42340052›Full record

ArticleAmerican journal of hematology2026

Impact of Atrial Fibrillation on the Risk of Thrombosis and Bleeding for Patients With Polycythemia Vera and Essential Thrombocytosis in the Real World.

Rodrigo Ortega Perez, Luis Manuel Domínguez Rodríguez, Francisca Ferrer-Marín, Beatriz Cuevas Ruíz, Clara Martínez Valverde, Patricia Vélez Tenza, María Isabel Mata Vázquez, Adrián Segura Díaz, María Laura Fox, Elvira Mora and 10 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in American journal of hematology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Rodrigo Ortega PerezCardiology Department, Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain.ORCID https://orcid.org/0000-0001-7017-9868
Luis Manuel Domínguez RodríguezCardiology Department, Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain.
Francisca Ferrer-MarínHematology Department, CIBERER-UCAM, Hospital J.M Meseguer, Murcia, Spain.
Beatriz Cuevas RuízHematology Department, Hospital Universitario de Burgos, Burgos, Spain.
Clara Martínez ValverdeHematology Department, Hospital Santa Creu i Sant Pau i la Santa Creu, Barcelona, Spain.
Patricia Vélez TenzaHematology Department, Hospital del Mar, Barcelona, Spain.
María Isabel Mata VázquezHematology Department, Complejo Hospital Costa del Sol, Marbella, Spain.
Adrián Segura DíazHematology Department, Hospital Universitario Gran Canaria Dr. Negrín, Las Palmas de Gran Canaria, Spain.
María Laura FoxHematology Department, Hospital Universitario Vall d ́Hebron, Barcelona, Spain.
Elvira MoraHematology Department, Hospital Universitario y Politécnico la Fe de Valencia, Valencia, Spain.
Manuel Mateo Pérez EncinasHematology Department, Complejo Hospitalario Universitario de Santiago. University of Santiago de Compostela, Santiago de Compostela, Spain.
Mercedes Gasior KabatHematology Department, Hospital Universitario La Paz, Madrid, Spain.
Gonzalo Carreño-TarragonaHematology Department, Hospital Universitario 12 de Octubre, Madrid, Spain.ORCID https://orcid.org/0000-0002-9570-5542
Rafael Andrés Del OrbeHematology Department, Hospital Universitario de Cruces, Baracaldo, Spain.
Gonzalo Caballero-NavarroHematology Department, Hospital Universitario Miguel Servet, Zaragoza, Spain.
Elena Magro MazoHematology Department, Hospital Universitario Príncipe de Asturias, Madrid, Spain.
Ana Pardo SanzCardiology Department, Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain.
José Luis Zamorano GómezCardiology Department, Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain.
Alberto Álvarez LarránHematology Department, Hospital Clínic de Barcelona, Barcelona, Spain.
Valentín Garcia-GutierrezHematology Department, Hospital Universitario Ramón y Cajal. IRYCIS. Universidad de Alcalá, Madrid, Spain.

Funding

Spanish Group of Ph-negative Myeloproliferative Neoplasms (GEMFIN)
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

anticoagulant therapyatrial fibrillationessential thrombocythemiamyeloproliferative neoplasmspolycythemia vera

Identifiers

PMID42340052
PMCPMC13428407

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.